Improving safety and drug development for infectious diseases and bioterrorism
Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery
This study is all about making a special lab at the University of Tennessee better at creating new medicines, vaccines, and tests to help keep everyone safe from new diseases and threats, and it’s designed for anyone interested in how we can be better prepared for health emergencies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Health Sci Ctr NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project ID | NIH-10910179 on NIH RePORTER |
What this research studies
This research focuses on enhancing the capabilities of the University of Tennessee Health Science Center's Regional Biocontainment Laboratory to develop new drugs, vaccines, and diagnostics aimed at protecting the public from emerging infectious diseases and bioterrorism threats. The project will create specialized cores to support laboratory operations and facilitate research on medical countermeasures. By fostering collaboration among academic, government, and commercial entities, the research aims to improve preparedness and response to potential pandemics and bioterrorism events.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk for emerging infectious diseases or those involved in biodefense efforts.
Not a fit: Patients with stable, non-infectious conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective treatments and preventive measures against serious infectious diseases and bioterrorism threats.
How similar studies have performed: Previous research in biocontainment and drug development has shown success in improving responses to infectious disease outbreaks and bioterrorism threats.
Where this research is happening
Memphis, United States
- University of Tennessee Health Sci Ctr — Memphis, United States (Active)
Researchers
- Principal investigator: Jonsson, Colleen B — University of Tennessee Health Sci Ctr
- Study coordinator: Jonsson, Colleen B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.